Trinity Biotech - 30 Year Stock Price History | TRIB
Historical daily share price chart and data for Trinity Biotech since 1995 adjusted for splits and dividends. The latest closing stock price for Trinity Biotech as of March 27, 2025 is 0.67.
- The all-time high Trinity Biotech stock closing price was 140.69 on March 08, 2000.
- The Trinity Biotech 52-week high stock price is 3.55, which is 429.9% above the current share price.
- The Trinity Biotech 52-week low stock price is 0.63, which is 6% below the current share price.
- The average Trinity Biotech stock price for the last 52 weeks is 1.60.
| Trinity Biotech Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.7955 | 0.9499 | 1.3600 | 0.6400 | 0.6675 | -24.16% |
| 2024 | 1.9634 | 2.1975 | 3.4600 | 0.7700 | 0.8802 | -58.97% |
| 2023 | 4.1112 | 5.3000 | 5.9000 | 1.8775 | 2.1450 | -56.67% |
| 2022 | 6.0935 | 7.1880 | 7.2000 | 4.6000 | 4.9500 | -30.77% |
| 2021 | 15.3580 | 18.0500 | 33.2000 | 7.1500 | 7.1500 | -62.47% |
| 2020 | 10.2946 | 5.3500 | 23.8500 | 3.1000 | 19.0500 | 268.69% |
| 2019 | 9.7142 | 11.5500 | 16.1000 | 3.4655 | 5.1670 | -54.87% |
| 2018 | 22.0923 | 25.9000 | 30.3000 | 10.7000 | 11.4500 | -55.10% |
| 2017 | 28.3044 | 34.8000 | 35.2000 | 22.5000 | 25.5000 | -26.30% |
| 2016 | 51.5808 | 58.4000 | 67.6500 | 31.5500 | 34.6000 | -41.16% |
| 2015 | 78.9833 | 89.6500 | 99.0348 | 54.1500 | 58.8000 | -32.01% |
| 2014 | 108.9240 | 121.9120 | 136.3985 | 79.2773 | 86.4888 | -29.71% |
| 2013 | 93.3408 | 71.0233 | 125.4357 | 70.5395 | 123.0376 | 76.36% |
| 2012 | 58.2618 | 48.2275 | 74.5068 | 46.9860 | 69.7654 | 43.52% |
| 2011 | 46.1195 | 40.4660 | 51.7132 | 39.2369 | 48.6095 | 16.72% |
| 2010 | 29.0569 | 18.8030 | 42.0733 | 18.1530 | 41.6479 | 118.07% |
| 2009 | 15.1613 | 7.7528 | 23.4003 | 4.9637 | 19.0985 | 152.50% |
| 2008 | 17.5522 | 31.1532 | 32.8550 | 5.9092 | 7.5637 | -76.51% |
| 2007 | 46.7815 | 41.5533 | 55.5463 | 27.0404 | 32.1937 | -20.54% |
| 2006 | 40.5138 | 38.8115 | 45.0988 | 33.5168 | 40.5133 | 5.02% |
| 2005 | 38.8107 | 55.4044 | 55.4044 | 29.6877 | 38.5751 | -31.08% |
| 2004 | 61.5096 | 100.4087 | 100.4087 | 47.8407 | 55.9717 | -46.95% |
| 2003 | 52.4709 | 27.4186 | 117.0300 | 23.6367 | 105.5142 | 313.33% |
| 2002 | 25.4535 | 28.3640 | 34.7932 | 17.5857 | 25.5276 | -11.18% |
| 2001 | 36.1760 | 42.5461 | 56.7281 | 21.5567 | 28.7422 | -32.44% |
| 2000 | 63.3991 | 33.0914 | 140.6857 | 33.0914 | 42.5461 | 33.14% |
| 1999 | 32.3208 | 27.7968 | 42.5461 | 21.9349 | 31.9568 | 29.01% |
| 1998 | 34.3513 | 38.9533 | 48.4080 | 17.7748 | 24.7713 | -33.50% |
| 1997 | 47.9408 | 43.6806 | 59.7536 | 30.8223 | 37.2514 | -15.81% |
| 1996 | 70.1485 | 68.4519 | 120.6417 | 42.5461 | 44.2479 | -39.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.015B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |